Akagera Medicines, Inc Email Formats
Biotechnology Research • 
Boston, Massachusetts, United States • 11-20 Employees
Akagera Medicines, Inc Email Formats
Akagera Medicines, Inc uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
Key Contacts at Akagera Medicines, Inc
Michael Fairbanks
Co-Founder, Chairman Of The Board, Chief Executive Officer
Douglas Moore
Senior Director Of Quality And Cmc Operations
Company overview
| Headquarters | Boston, Massachusetts, United States |
| Website | |
| Employees | 11-20 |
| Socials |
About Akagera Medicines, Inc
Akagera Medicines is a private Delaware-registered company that develops novel and patented liposomal formulations of antibacterial drugs to treat tuberculosis and other infectious diseases. The company was founded in 2018 in Kigali, Rwanda. It is well-funded, majority-owned by the people of Rwanda, and has laboratories in Boston and San Francisco. Akagera registered a 100%-owned subsidiary in Kigali in 2022 to do manufacturing and clinical trials in the future. Liposomal therapeutics represent a well-validated platform of drug delivery systems that are used for the treatment of a wide range of diseases. They include systemic fungal infections, mycobacterium avium, and cancers. They are utilized to alter the biodistribution of the encapsulated drug and the exposure profile for the drug, and impact both the efficacy and the toxicity (the therapeutic index) of the active drug. The company has developed a therapeutic for MRSA, and vaccine candidates for Tuberculosis, Lassa Fever, HIV, RSV, and Influenza. The vaccine candidates are being developed in close partnership with THE GATES FOUNDATION, the National Institute of Health (NIH) – Vaccine Research Council (VRC), the Coalition for Epidemic Preparedness Innovations (CEPI), and a public pharmaceutical company.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Akagera Medicines, Inc has 4 employees across 3 departments.
Departments
Number of employees
Funding Data
Akagera Medicines, Inc has never raised funding before.
Akagera Medicines, Inc Tech Stack
Discover the technologies and tools that power Akagera Medicines, Inc's digital infrastructure, from frameworks to analytics platforms.
CMS
Ecommerce
Security
Portugal
Spain
Malta
Germany
SwedenFrequently asked questions
4.8
40,000 users
